Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clients have the option of selecting from two different PA criteria a stricter version that aligns with the population in the clinical trial and another version based on the current labeled indication
42 The FIGHT trial, which enrolled patients hospitalised for acute decompensated HFrEF, showed no improvement with liraglutide on the primary composite endpoint of death, HF rehospitalisation or change in N-terminal pro B-type natriuretic peptide levels
Her new husband has helped keep her active and committed to a healthy lifestyle
Patients who do not make significant lifestyle changes are more likely to require long-term treatment to prevent weight regain
Responsive customer service
US$ 28.58
US$ 25.50
US$ 21.91
US$ 29.89
